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Abstract: BACKGROUND Magnetic resonance imaging (MRI)-guided laser interstitial thermal therapy
(MRIgLITT) was demonstrated to be a viable neurosurgical tool. Apart from its variety of indications,
different operative and technical nuances exist. In the present report, for the first time, the use and
ability of a traditional Riechert-Mundinger (RM) stereotactic system combined with a novel drill guide
kit for MRIgLITT are described. METHODS A stereotactic frame-based setting was developed by
combining an RM system with a drill guide kit and centering bone anchor screwing aid for application
together with an MRIgLITT neuro-accessory kit and cooled laser applicator system. The apparatus was
used for stereotactic biopsy and consecutive MRIgLITT with an intraoperative high-field MRI scanner
in a brain tumor case. RESULTS The feasibility of an RM stereotactic apparatus and a drill guide
kit for MRIgLITT was successfully assessed. Both stereotactic biopsy and subsequent MRIgLITT in a
neurooncological patient could easily and safely be performed. No technical problems or complications
were observed. CONCLUSION The combination of a traditional RM stereotactic system, a new drill
guide tool, and intraoperative high-field MRI provides neurosurgeons with the opportunity to reliably
confirm the diagnosis by frame-based biopsy and allows for stable and accurate real-time MRIgLITT.
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Abstract
Background Magnetic resonance imaging (MRI)-guided laser interstitial thermal therapy (MRIgLITT) was demonstrated 
to be a viable neurosurgical tool. Apart from its variety of indications, different operative and technical nuances exist. In the 
present report, for the first time, the use and ability of a traditional Riechert-Mundinger (RM) stereotactic system combined 
with a novel drill guide kit for MRIgLITT are described.
Methods A stereotactic frame-based setting was developed by combining an RM system with a drill guide kit and center-
ing bone anchor screwing aid for application together with an MRIgLITT neuro-accessory kit and cooled laser applicator 
system. The apparatus was used for stereotactic biopsy and consecutive MRIgLITT with an intraoperative high-field MRI 
scanner in a brain tumor case.
Results The feasibility of an RM stereotactic apparatus and a drill guide kit for MRIgLITT was successfully assessed. Both 
stereotactic biopsy and subsequent MRIgLITT in a neurooncological patient could easily and safely be performed. No tech-
nical problems or complications were observed.
Conclusion The combination of a traditional RM stereotactic system, a new drill guide tool, and intraoperative high-field 
MRI provides neurosurgeons with the opportunity to reliably confirm the diagnosis by frame-based biopsy and allows for 
stable and accurate real-time MRIgLITT.
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Introduction
Magnetic resonance imaging (MRI)-guided laser interstitial 
thermal therapy (MRIgLITT) is an inviting treatment option 
in neurosurgery. Using a stereotactically inserted laser appli-
cator, patients can be treated through an elegant and mini-
mally invasive approach.
At present, many clinical indications, surgical variations, 
and technical nuances for MRIgLITT exist [1, 2, 4, 5, 7]. 
Here, for the first time, a traditional Riechert-Mundinger 
(RM) stereotactic system [6] was implemented in combi-
nation with a novel drill guide kit for MRIgLITT. Based 
on a neurooncological case, the setting and procedure 
are described in detail and a discussion of its potential is 
provided.
Case presentation
A 65-year-old female presented to our hospital complaining 
of intermittent left-sided hemidysesthesia 11 days prior to 
admission. Additionally, she had a history of obstructive 
sleep apnea syndrome, chronic venous insufficiency, hyper-
tensive cardiac disease, coronary sclerosis, hyperuricemia, 
dyslipidemia, hypothyroidism, osteoarthritis, and glaucoma. 
Upon admission, she underwent comprehensive clinical 
assessment whereby the neurological examination revealed 
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mild hypesthesia of the left half of the body. Cranial MRI 
demonstrated a diffuse contrast-enhancing lesion accompa-
nied by perifocal edema within the right parietal operculum 
consistent with a high-grade glioma (Fig. 1a).
MRIgLITT was discussed between disciplines and 
offered to the patient as an alternative to open microsurgery. 
The indication for the procedure was based on multiple fac-
tors including the increased perioperative risk with reduced 
patient health status, multiple concomitant diseases, and the 
anatomical deep-seated subcortical tumor location. Written 
informed consents for surgery and general research for col-
lection of clinical data and use for academic or educational 
purposes were obtained from the patient. Local Review 
Board approval was not needed for this single report, as 
patient data was de-identified in compliance with institu-
tional requirements.
The patient underwent stereotactic biopsy with frozen 
sections and subsequent MRIgLITT for ablation of the right 
parietal lesion (Fig. 1b) as described in detail below. The 
histopathological examination confirmed the diagnosis of a 
glioblastoma grade IV according to the World Health Organ-
ization (WHO) Brain Tumor Classification System [9]. The 
patient was discharged on the fourth postoperative day. She 
received adjuvant combined radio-chemotherapy with con-
comitant alkylating agent temozolomide treatment according 
to the decision of the institutional interdisciplinary neuroon-
cological board. The further clinical course was uneventful 
with remittent sensory deficits. Only after 16 months follow-
ing surgery, routine MRI examinations showed signs highly 
suspect of tumor progression (Fig. 1c). This was clinically 
accompanied by mild left-sided hemiparesis whereupon due 
to the tumor growth under temozolomide therapy angiogen-
esis inhibition by bevacizumab was initiated.
Stereotactic frame‑based drill guide‑aided 
magnetic resonance imaging‑guided laser 
interstitial thermal therapy procedure
In the present report, an MRI-guided cooling and laser 
applicator system and neuro-accessory kit (Visualase®; 
Medtronic Navigation Inc., Louisville, CO, USA) for soft 
tissue ablation in open, percutaneous, and interstitial surgi-
cal procedures was used. The complete MRIgLITT setting 
comprises a targeting and insertion system, the laser ablation 
kit, and an intraoperative MRI scanner. All of the technol-
ogy employed was United States of America (USA) Food 
and Drug Administration (FDA) and European Medicines 
Evaluation Agency European Union (EU) Conformité Euro-
péenne (CE) marketing approved for the purposes described. 
Prior to the first application in a patient, an unproblematic 
separate dry run with MRIgLITT in a human artificial gel-
filled head model (Medtronic Inc., Minneapolis, MN, USA) 
was performed.
The patient underwent 3-Tesla (T) MRI (Magnetom® 
Skyra VD13; Siemens Healthcare GmbH, Erlangen, Ger-
many) examination for diagnostic workup and stereo-
tactic planning prior to surgery. Images were transferred 
to the StealthStation® S7® Surgical Navigation System 
(Medtronic Inc., Minneapolis, MN, USA). Optimal entry 
Fig. 1  Axial magnetic resonance imaging T1-weighted sequences 
demonstrating a diffuse contrast-enhancing lesion accompanied by 
perifocal edema within the right parietal operculum consistent with 
a high-grade glioma. a Preoperative at presentation. b Intraoperative 
after ablation with the laser probe inserted along the tumor extent. c 
Postoperative 16  months following surgery and adjuvant combined 
radio-chemotherapy revealing tumor progression
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site, transcortical and perlesional catheter placement trajec-
tory, and target were then determined, taking safe accessibil-
ity and ideal ablation coverage into account.
The day of surgery, the patient received general anes-
thesia and oral intubation. After standardized team time 
out and safe surgery check with the patient in supine posi-
tion, administration of intravenous single-dose antibiotics 
(1.5 g cefuroxime), and skin disinfection, the RM head-
frame was mounted with four screws under sterile condi-
tions and provided with a CT localization set consisting 
of four fiducial plates (Rev. A; Inomed Medizintechnik 
GmbH, Emmendingen, Germany). A contrast-enhanced 
CT (Somatom® X.cite; Siemens Healthcare GmbH, Erlan-
gen, Germany) examination for frame-based anatomical 
referenciation was obtained. CT images were automati-
cally stereo-localized by the Medtronic neuronavigation 
system and computationally fused with the preoperative 
MRI images for final planning. Following thorough adjust-
ment of the coordinates, the RM stereotactic bow was 
mounted on the ring.
The targeting and insertion system (Figs. 2 and 3) con-
sists of an RM stereotactic circular CT-adapted titanium or 
half-open MRI compatible ceramic base ring, a semicircu-
lar aiming bow, a fixed instrument holder, a localization set 
available for CT and MRI applications, and a target point 
simulator (Inomed Medizintechnik GmbH, Emmendingen, 
Germany) combined with a drill guide kit and bone anchor 
centering screwing aid (Inomed Medizintechnik GmbH, 
Emmendingen, Germany) along with a StealthStation® 
S7® planning station with software (Medtronic Inc., Min-
neapolis, MN, USA). The drill guide kit enables stereo-
tactic-based drilling with a Colibri II handpiece (DePuy 
Synthes, Raynham, MA, USA) and a 3.2-mm diameter 
and 30-cm length twist drill with a clumping screw (AD-
TECH Medical Instrument Corporation, Oak Creek, WI, 
USA) for insertion of a brain biopsy cannula of 2.1-mm 
diameter (Neuromedex GmbH, Hamburg, Germany) and 
a bone anchor (Medtronic Inc., Minneapolis, MN, USA) 
thereafter. The kit consists of a 3-piece (sleeve, guide with 
knurled screw, reducing tube) drill guidance of 3.2-mm 
inner diameter, 19.5-mm outer diameter, and a length of 
139 mm, a bone anchor centering screwing aid of 14-mm 
outer diameter and a length of 314.7 mm with hand grip, 
and a dove tail rail of 120-mm length for fixation on the 
RM bow.
After skin disinfection, sterile draping, and confirma-
tion of the entry point, a 4-mm stab incision with a surgi-
cal scalpel blade no. 11 was performed and the reducing 
tube was placed into the guidance to accommodate the 
drill. Once the craniostomy was created, the dura was 
perforated with a stiffening stylet with a length of 35 cm 
and a diameter of 1.6 mm (Visualase®; Medtronic Navi-
gation Inc., Louisville, CO, USA), and a histopathologi-
cal sampling with the side-cut brain biopsy cannula was 
performed.
The laser ablation kit used (Fig. 3) includes a titanium 
bone anchor, light source, laser fiber, 10-mm applicator tip, 
pump tubing set, and tubing extension. Before insertion, the 
Fig. 2  Schematic three-
dimensional diagram with 
incorporated photograph of the 
specialized targeting and inser-
tion system with a traditional 
Riechert-Mundinger apparatus 
and the novel drill guide kit. 
The stereotactic system includ-
ing semicircular aiming bow 
with fixed instrument holder 
(a) and circular base ring (b) is 
combined with the drill guide 
kit (c) and mounted on a human 
manikin for placement of a 
titanium bone anchor (d) via the 
centering screwing aid (e) and 




integrity and functionality of the laser catheter were con-
trolled, and the planned depth measured. To insert the laser 
applicator in the center of the target area, the drill guidance 
without the reducing tube was used to pass the centering 
screwing aid for fixation of the bone anchor with a length of 
4.1 cm and an outer diameter of 3.2 mm into the calvarian 
burr hole along the proper trajectory. This holds the laser 
applicator provided with a blue cap of 0.3-cm length. The 
sufficient passage of the anchor was controlled by an align-
ment rod of 26.7-cm length and diameter of 1.6 mm (Visu-
alase®; Medtronic Navigation Inc., Louisville, CO, USA). 
Once in place, the RM bow was removed, and the catheter 
was passed to the appropriate depth. Upon reaching the tar-
get, it was secured to the bone anchor by tightening the cap. 
Subsequently, the RM frame and screws were removed.
Intraoperative high-field MRI was performed using an 
8-channel head coil (NORAS MRI products, Hoechberg, 
Germany) in a 3-T MRI machine (Magnetom® Skyra VD13; 
Siemens Healthcare GmbH, Erlangen, Germany). This enabled 
simultaneous imaging of the lesion, laser probe location, and 
thermometry for real-time monitoring of tissue ablation (Fig. 4 
a and b). A 3-step checklist for safety in the intraoperative MRI 
suite [8] was applied. Following the last step on the list, the 
patient was transferred to the adjacent suite, one door separat-
ing from the operation room, and positioned in the scanner.
The laser applicator was connected with an ethernet cable 
to the physician workstation in the MRI control room. A 
three-dimensional preablation MRI scan was acquired as 
a reference imaging. From this image, the correct target 
position of the applicator was confirmed, and appropriate 
treatment planes were identified. Thereafter, a test dose was 
delivered. The preferred thermal plain images were selected, 
and temperature checkpoints identified. High-temperature 
limits were set near the tip of the applicator, whereas low-
temperature limits were set at the borders of the target area 
and near critical structures. Real-time thermal damage was 
estimated and MRIgLITT was delivered (Fig. 4a and b).
A postprocedural MRI scan (Fig. 1b) to evaluate the extent 
of ablation was obtained and merged with the preprocedural 
images. Based on the planned trajectory, the correctness of the 
laser applicator insertion and tip position and accuracy of the 
thermal therapy were verified. Following completion of the 
operation, the applicator and anchor were withdrawn as one 
piece to avoid shearing off portions of the catheter. Thereafter, 
the skin incision was closed by a single stich 3.0-prolene non-
absorbable suture under sterile conditions. Finally, the patient 
was awakened from general anesthesia, extubated, and trans-
ferred to the neurosurgical intermediate care unit for postop-
erative monitoring.
Discussion
With recent CE marking of MRIgLITT, its availability and 
popularity especially in Europe are quickly expanding. There 
is now an increasing need for alternative and novel adjustments 
to enable individual use of the method and to allow more cent-
ers to treat patients with MRIgLITT according to the neuro-
surgeon’s personal experience, familiarity and preference, the 
Fig. 3  Schematic three-
dimensional diagrams of the 
dedicated insertion and ablation 
equipment applied in the novel 
stereotactic frame-based and 
drill guide-aided setting for 
brain biopsy, laser applica-
tor placement, and magnetic 
resonance imaging-guided inter-
stitial thermal therapy. Insertion 
kit including a dove tail rail (a), 
sleeve (b), guide (c), reducing 
tube (d), screwing aid (e), twist 
drill (f), and clumping screw 
(g). Laser ablation kit compris-
ing an alignment rod (h), bone 




institution’s own facilities, recourses, and infrastructure, and 
the local health care systems.
Surgical and technical variations and nuances for 
MRIgLITT are manifold and comprise both frame-based [2, 
4, 5] and frameless [1, 4, 5, 7] approaches, although most of 
the previous studies described the use of a frame [4]. All of 
these settings seem to allow laser applicator placement with 
an acceptable accuracy, yet sufficient corresponding data and 
comparative studies are widely lacking. No single system has 
provided clear benefit over another and each has its inherent 
advantages and disadvantages [5]. However, frame-based 
stereotaxy seems to be associated with lower complication 
rates and reduced numbers of applicator placements when 
compared to frameless methods [1].
Setting advantages and disadvantages
The RM apparatus is relatively heavy and cumbersome, 
its montage, adjustment, and application are complex and 
require some experience, and the system is based on the 
more unusual translational principle and polar coordinate 
system. Nevertheless, image quality is excellent and arti-
facts on neuroimages rarely occur with the RM apparatus. 
Moreover, due to its construction and 3-point fixation on 
the base ring, it has an extremely high mechanical stability 
and target accuracy.
With the help of the advanced target point simulator, 
which allows to detect miscalculations, maladjustments, 
and even bending of the instruments and deviations of 
their axis, the adjusted coordinates can be directly checked 
[3, 6]. Apart from the Zamorano-Dujovny (ZD) bow used 
with the same simulator and base ring, and the Brown-
Roberts-Wells (BRW) and Cosman-Roberts-Wells (CRW) 
frames with their own target verification simulators, the 
ring-based RM stereotactic system is the only one world-
wide with this so-called phantom. Theoretical planning 
from the software tools can be directly measured and veri-
fied according to the real-world geometric environment 
ensuring optimal precision and maximal safety. It allows 
safety checks to ensure instruments are applied and func-
tioning properly and within acceptable tolerances prior to 
neurosurgical intervention.
Although in principle any target within the brain can be 
reached from any entrance point with the RM device [3], 
access in the posterior and inferior part of the skull and 
especially in the suboccipital region bears some intrinsic 
limitations in the frame positioning. Consequently, this 
might require meticulous stereotactical planning, adjust-
ments of ring and bow fixation, and thus modifications 
of the procedures. Issues are not as readily apparent with 
several of the lower-profile frame-based and frameless 
approaches.
Additionally, the drill guide kit and centering screwing aid 
applied in this case can significantly contribute to the stability 
and accuracy of the entire setting. They help avoid drill devia-
tion especially when drilling more tangentially to the skull 
and support precise insertion of the laser applicator into the 
bone anchor. No similar and comparable system is described 
and available. The kit can also be utilized for the ZD bow 
(Inomed, Medizintechnik GmbH, Emmendingen, Germany) 
as well as for the Leksell® G and the Vantage™ stereotactic 
systems (Elekta Instruments AB, Stockholm, Sweden).
Although at our institution further stereotactic options 
such as frame-associated neurosurgical robots, frameless 
arm-based systems, a mobile CT, and the intraoperative 
MRI are available, the RM apparatus is routinely used. 
Rationale for selecting the RM apparatus include the avail-
ability of a phantom, an accuracy within 1 mm (unpub-
lished data), reduced need for additional equipment, and 
a shorter procedure time compared to some of the other 
settings. When compared to other laser applicator inser-
tion systems such as frameless articulated arms (Variogu-
ide™; Brainlab AG, Feldkirchen, Germany and Vertek®; 
Fig. 4  Images of tumor ablation 
after stereotactic frame-based 
and drill guide-aided brain 
biopsy and laser probe inser-
tion. a Axial contrast-enhanced 
real-time magnetic resonance 
imaging for thermometry. b 
Monitoring of thermal damage 
during the magnetic resonance 
imaging-guided interstitial 
thermal therapy procedure 




Medtronic Inc., Minneapolis, MN, USA) and less heavy 
frame-based options such as the ZD, Leksell, and CRW 
(Integra LifeSciences, Plainsboro, NJ, USA) system, the 
setting described with its highly stable and accurate RM 
frame combined with the rigid drill guide kit maximally 
reduces the risk of bone anchor dislocation and inadequate 
laser probe placement. Moreover, the target point simula-
tor allows direct control of correctness of adjusted coordi-
nates. Although less stable, the frameless approaches and 
trajectory-guided skull-mounted mini-frames such as the 
ClearPoint® (MRI Interventions Inc., Irvine, CA, USA) 
and STarFix™ (FHC Inc., Bowdoin, ME, USA) system 
along with some of the frame-based alternatives might 
allow the surgeon a higher flexibility to insert the laser 
applicator. The use of the CRW frame with the Visualase® 
kit requires calculation of an offset to accommodate the 
bone anchor in cases of longer trajectories. Mini-frame 
platforms can be used to perform MRIgLITT entirely in 
the MRI suite. Frameless neuronavigation-based systems 
and some robotic platforms such as the ROSA ONE® Brain 
(Zimmer Biomet Robotics, Montpellier, France) can be 
used completely without frames especially for cases of 
larger lesions and longer trajectories but require anatomical 
registration in-bone fiducials that have to be inserted into 
and later removed from the skull. We alternatively apply 
the drill guide kit with the Leksell® G frame combined 
with a neuromate® robotic system (Renishaw, Gloucester-
shire, UK) using individual self-constructed tubes.
Especially as the drill has a heavy handpiece and can pro-
duce high vibrations during drilling, a maximum of stability is 
desired. This stability is what the implemented system provides 
beyond other set-ups described previously, apart from robotic 
systems. What is more is it allows centers already utilizing the 
RM apparatus to directly perform MRIgLITT and provides an 
excellent alternative to other methods of brain biopsy and laser 
probe placement. In our experience, the high stability and preci-
sion of the combined targeting system and insertion kit predis-
pose for the use in laser applicator placement and MRIgLITT.
Study limitations
The present report is limited to just a single MRIgLITT appli-
cation. As such, further comparative assessments are desired. 
However, the purpose was not to evaluate the advantages and 
disadvantages of competing MRIgLITT approaches nor to 
decidedly compare our findings to other stereotactic systems 
and laser ablation techniques. We focused specifically on the 
utility of the setting described and could elucidate that the com-
bination of an RM system combined with the drill guide kit is 
feasible and a useful tool for stereotactic frame-based biopsy 
and MRIgLITT. Given the importance of the highly emerging 
and rapidly increasing method of MRIgLITT, we were encour-
aged to describe our setting at this early stage and felt that it was 
important to share our preliminary experience.
Conclusion
We present the first report on the application of a traditional 
RM stereotactic system combined with a newly developed 
drill guide kit for the use in MRIgLITT. This setting and 
procedure proved to be stable, accurate, and reliable for both 
stereotactic frame-based biopsies and in combination with 
MRIgLITT when properly applied.
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Comments 
In this paper, Oertel and colleagues describe an innovation they have 
devised for use with a commercially available cranial laser ablation 
system allowing a Riechert-Mundinger (RM) stereotactic system to 
support both the stereotactic drilling and bone anchor placement steps 
of the procedure. This procedure, like all stereotactic procedures, has 
as its Achilles heel the possibility of being off target. The chance of 
this happening is an accumulation of the individual errors that come 
with each of the steps of the procedure, from imaging, to registration, 
drilling, anchor placement, and probe insertion, among others. Those 
who have done this procedure will know that there is certainly the 
prospect of error being introduced from the wobble of the drill as 
it enters the skull as well as from the securing of the anchor to the 
skull. The accuracy of the laser probe trajectory is almost solely based 
on the degree to which the bone anchor is rectilinear to the planned 
trajectory: it is therefore imperative to securing it straight. The current 
anchor with titanium threads is much superior to the original system 
with synthetic threads in this regard. There is, however, still the 
chance of wobble being introduced as the anchor is secured. While 
this preliminary report does not prove that the authors’ system solves 
this problem and improves accuracy, it does appear prima facie to 
be a more stable method of drilling and securing the anchor than the 
standard system. The system does appear to address the two major 
accuracy failure points of the system. Further results in clinical use 
will be necessary to establish whether the system does actually provide 
more stability and accuracy, especially for the deep and small targets 
where exact placement is the most crucial. It does not appear that 
the system described would be expensive or difficult to make widely 
available. Surgeon-driven innovation is most welcome to drive ongoing 




Oertel and co-workers are the first to report on the use of a Riechert-
Mundinger (RM) stereotactic system combined with a novel drill guide 
kit for laser interstitial thermal therapy (LITT). Since LITT can be 
implemented using different surgical and technical variations, as the 
authors themselves point out, it is important these be tailored to the 
individual neurosurgeons experience and available resources. As such, 
centers familiar with the RM stereotactic system might find inspiration 
in this technical note as how to proceed with the implementation of 
LITT at their respective center, while taking advantage of their 
experience with the RM system.
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